Therapeutic Plasma Exchange Management for a Pediatric Patient Presenting With Immune Thrombotic Thrombocytopenic Purpura in a Setting of Common Variable Immunodeficiency

被引:0
|
作者
Budhipramono, Albert [1 ]
Sharma, Ruchika [2 ,3 ]
Wysocki, Christian Allen [2 ,4 ]
Zia, Ayesha N. [2 ,3 ]
Adkins, Brian D. [1 ,2 ]
机构
[1] Univ Texas Southwestern Med Ctr, Dept Pathol, Dallas, TX 75390 USA
[2] Childrens Hlth Syst, Dallas, TX 75235 USA
[3] Univ Texas Southwestern Med Ctr, Dept Pediat, Div Hematol & Oncol, Dallas, TX USA
[4] Univ Texas Southwestern Med Ctr, Dept Pediat, Div Allergy & Immunol, Dallas, TX USA
关键词
common variable immunodeficiency; pediatric apheresis; thrombotic thrombocytopenic purpura; CAPLACIZUMAB; SCORE; MICROANGIOPATHY; DEFICIENCY; RITUXIMAB; ANTIBODY; REGISTRY; TTP;
D O I
10.1002/jca.22154
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Common variable immunodeficiency (CVID) is a disorder characterized by hypogammaglobulinemia resulting in recurrent infections. While autoimmune disorders are common in patients with CVID, no association has been reported between CVID and immune thrombotic thrombocytopenic purpura (iTTP), a disorder most often caused by autoantibodies that compromise the activity of the enzyme ADAMTS13. Reduced ADAMTS13 activity results in the accumulation of large von Willebrand factor multimers that can consume platelets and cause microvascular thrombosis and organ injury, ultimately resulting in mortality in most cases of untreated iTTP. Here, we report a 12-year-old male with CVID who developed iTTP, underwent therapeutic plasma exchange (TPE), and subsequently recovered. We conducted a systematic review for other cases of CVID co-occurring with iTTP and present additional cases of this rare presentation. We highlight the importance of prompt recognition of iTTP in a patient with CVID and timely initiation of TPE.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Successful treatment of thrombotic thrombocytopenic purpura with repeated plasma exchange in a patient with microscopic polyangitis
    Nagai, Koji
    Kotani, Takuya
    Takeuchi, Tohru
    Shoda, Takeshi
    Hata-Kobayashi, Ayu
    Wakura, Daisuke
    Kagitani, Maki
    Makino, Shigeki
    Hanafusa, Toshiaki
    MODERN RHEUMATOLOGY, 2008, 18 (06) : 643 - 646
  • [22] Partial response to anti-CD20 monoclonal antibody treatment of severe immune thrombocytopenic purpura in a patient with common variable immunodeficiency
    Carbone, J
    Escudero, A
    Mayayo, M
    Ballesteros, M
    Perez-Corral, A
    Sanchez-Ramon, S
    Sarmiento, E
    Micheloud, D
    Fernandez-Cruz, E
    AUTOIMMUNE DISEASES AND TREATMENT: ORGAN-SPECIFIC AND SYSTEMIC DISORDERS, 2005, 1051 : 666 - 671
  • [23] Management of thrombotic thrombocytopenic purpura without plasma exchange: the Jehovah's Witness experience
    George, James N.
    Sandler, Steven A.
    Stankiewicz, Joanna
    BLOOD ADVANCES, 2017, 1 (24) : 2161 - 2165
  • [24] Patients with thrombotic thrombocytopenic purpura commonly develop metabolic alkalosis during therapeutic plasma exchange
    Marques, MB
    Huang, ST
    JOURNAL OF CLINICAL APHERESIS, 2001, 16 (03) : 120 - 124
  • [25] Cyclosporine or steroids as an adjunct to plasma exchange in the treatment of immune-mediated thrombotic thrombocytopenic purpura
    Cataland, Spero R.
    Kourlas, Peter J.
    Yang, Shangbin
    Geyer, Susan
    Witkoff, Leslie
    Wu, Haiwa
    Masias, Camila
    George, James N.
    Wu, Haifeng M.
    BLOOD ADVANCES, 2017, 1 (23) : 2075 - 2082
  • [26] Deterioration of gas exchange in patients with severe thrombotic thrombocytopenic purpura with respiratory failure during therapeutic plasma exchange
    Baz, EMK
    Khatib, MF
    Mahfouz, RAR
    Jamaleddine, GW
    JOURNAL OF CLINICAL APHERESIS, 2001, 16 (03) : 143 - 147
  • [27] Combination of Fresh Frozen Plasma and Cryosupernatant Plasma for Therapeutic Plasma Exchange in Thrombotic Thrombocytopenic Purpura: A Single Institution Experience
    Lin, Qiuyan
    Fan, Liping
    Huang, Haobo
    Zeng, Feng
    Fu, Danhui
    Wei, Shijin
    BIOMED RESEARCH INTERNATIONAL, 2019, 2019
  • [28] Immature platelet dynamics in management of protracted response to therapy of a young pediatric patient with immune-mediated thrombotic thrombocytopenic purpura
    Maitta, Robert W.
    Reeves, Hollie M.
    Downes, Katharine A.
    He, Xiangrong
    Hackney, Lisa R.
    Ahuja, Sanjay P.
    THROMBOSIS RESEARCH, 2023, 228 : 145 - 147
  • [29] Pharmacokinetics of cefoperazone/sulbactam in critically Ill thrombotic thrombocytopenic purpura patients undergoing therapeutic plasma exchange
    Li, Haitao
    Gao, Chunlu
    Lin, Liwang
    Zhang, Gensheng
    Fan, Shengjin
    Hai, Xin
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2022, 47 (08) : 1232 - 1239
  • [30] Early relapse of thrombotic thrombocytopenic purpura during therapeutic plasma exchange associated with Acinetobacter anitratus bacteremia
    Kanj, NA
    Mikati, ARA
    Baz, EMK
    THERAPEUTIC APHERESIS AND DIALYSIS, 2003, 7 (01): : 119 - 121